Cargando…

Therapeutic Peptides to Treat Myocardial Ischemia-Reperfusion Injury

Cardiovascular diseases (CVD) including acute myocardial infarction (AMI) rank first in worldwide mortality and according to the World Health Organization (WHO), they will stay at this rank until 2030. Prompt revascularization of the occluded artery to reperfuse the myocardium is the only recommende...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernandez Rico, Carlota, Konate, Karidia, Josse, Emilie, Nargeot, Joël, Barrère-Lemaire, Stéphanie, Boisguérin, Prisca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891520/ https://www.ncbi.nlm.nih.gov/pubmed/35252383 http://dx.doi.org/10.3389/fcvm.2022.792885

Ejemplares similares

Anti-apoptotic peptide for long term cardioprotection in a mouse model of myocardial ischemia–reperfusion injury
por: Covinhes, Aurélie, et al.
Publicado: (2020)

Peptide-Based Nanoparticles for Therapeutic Nucleic Acid Delivery
por: Boisguérin, Prisca, et al.
Publicado: (2021)

PPARβ/δ Is Required for Mesenchymal Stem Cell Cardioprotective Effects Independently of Their Anti-inflammatory Properties in Myocardial Ischemia-Reperfusion Injury
por: Nernpermpisooth, Nitirut, et al.
Publicado: (2021)

Editorial: New Strategies to Inhibit Cell Death in Myocardial Ischemia-Reperfusion Injury: How to Succeed?
por: Barrère-Lemaire, Stéphanie, et al.
Publicado: (2022)

The cardioprotective effects of secretory leukocyte protease inhibitor against myocardial ischemia/reperfusion injury
por: Prompunt, Eakkapote, et al.
Publicado: (2018)

Editorial: New strategies to inhibit cell death in myocardial ischemia-reperfusion injury: how to succeed? Volume II
por: Kumphune, Sarawut, et al.
Publicado: (2023)

Heart rate reduction after genetic ablation of L-type Ca(v)1.3 channels induces cardioprotection against ischemia-reperfusion injury
por: Delgado-Betancourt, Viviana, et al.
Publicado: (2023)

Acute and long-term cardioprotective effects of the Traditional Chinese Medicine MLC901 against myocardial ischemia-reperfusion injury in mice
por: Vincent, Anne, et al.
Publicado: (2017)

WRAP-based nanoparticles for siRNA delivery: a SAR study and a comparison with lipid-based transfection reagents
por: Konate, Karidia, et al.
Publicado: (2021)

PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia–reperfusion injury
por: Sarre, Charlotte, et al.
Publicado: (2022)

Correction: PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia–reperfusion injury
por: Sarre, Charlotte, et al.
Publicado: (2022)

In Vivo Follow-Up of Gene Inhibition in Solid Tumors Using Peptide-Based Nanoparticles for siRNA Delivery
por: Ferreiro, Isabel, et al.
Publicado: (2021)

Highway to Cell: Selection of the Best Cell-Penetrating Peptide to Internalize the CFTR-Stabilizing iCAL36 Peptide
por: Seisel, Quentin, et al.
Publicado: (2022)

Post-Ischemic Treatment of Recombinant Human Secretory Leukocyte Protease Inhibitor (rhSLPI) Reduced Myocardial Ischemia/Reperfusion Injury
por: Mongkolpathumrat, Podsawee, et al.
Publicado: (2021)

Calpain: the regulatory point of myocardial ischemia-reperfusion injury
por: Liu, Guo-Yang, et al.
Publicado: (2023)

A retro-inverso cell-penetrating peptide for siRNA delivery
por: Vaissière, Anaïs, et al.
Publicado: (2017)

Promising Therapeutic Candidate for Myocardial Ischemia/Reperfusion Injury: What Are the Possible Mechanisms and Roles of Phytochemicals?
por: Chen, Cong, et al.
Publicado: (2022)

Preclinical multi-target strategies for myocardial ischemia-reperfusion injury
por: Li, Yuqing, et al.
Publicado: (2022)

Myocardial Ischemia-Reperfusion and Diabetes: Lessons Learned From Bedside to Bench
por: Dia, Maya, et al.
Publicado: (2021)

A bibliometric analysis of myocardial ischemia/reperfusion injury from 2000 to 2023
por: Wang, Yifei, et al.
Publicado: (2023)

Myocardial oxidative stress is increased in early reperfusion, but systemic antioxidative therapy does not prevent ischemia-reperfusion arrhythmias in pigs
por: Haugsten Hansen, Marie, et al.
Publicado: (2023)

Association of GSDMD with microvascular-ischemia reperfusion injury after ST-elevation myocardial infarction
por: Sun, Wenjing, et al.
Publicado: (2023)

Combination of metformin and p38 MAPK inhibitor, SB203580, reduced myocardial ischemia/reperfusion injury in non-obese type 2 diabetic Goto-Kakizaki rats
por: Sanit, Jantira, et al.
Publicado: (2019)

Influence of Intrinsic Aerobic Exercise Capacity and Sex on Cardiac Injury Following Acute Myocardial Ischemia and Reperfusion
por: Alsahly, Musaad B., et al.
Publicado: (2021)

PPARγ Mediates the Cardioprotective Roles of Danlou Tablet After Acute Myocardial Ischemia-Reperfusion Injury
por: Wei, Meng, et al.
Publicado: (2022)

Ginsenoside Rg2 Ameliorates Myocardial Ischemia/Reperfusion Injury by Regulating TAK1 to Inhibit Necroptosis
por: Li, Yao, et al.
Publicado: (2022)

Renal Denervation Attenuates Adverse Remodeling and Intramyocardial Inflammation in Acute Myocardial Infarction With Ischemia–Reperfusion Injury
por: Wang, Kun, et al.
Publicado: (2022)

Oral Supplementation With Butyrate Improves Myocardial Ischemia/Reperfusion Injury via a Gut-Brain Neural Circuit
por: Yu, Zhiyao, et al.
Publicado: (2021)

Electroacupuncture Pretreatment Mitigates Myocardial Ischemia/Reperfusion Injury via XBP1/GRP78/Akt Pathway
por: Wang, Nisha, et al.
Publicado: (2021)

A new method for the treatment of myocardial ischemia-reperfusion injury based on γδT cell-mediated immune response
por: Luo, Wei, et al.
Publicado: (2023)

Optical Activation of the Dorsal Horn of the Thoracic Spinal Cord Prevents Ventricular Arrhythmias in Acute Myocardial Ischemia-Reperfusion Rats
por: Wu, Yong, et al.
Publicado: (2022)

Cardioprotective Effects and Possible Mechanisms of Luteolin for Myocardial Ischemia-Reperfusion Injury: A Systematic Review and Meta-Analysis of Preclinical Evidence
por: Pan, Qinyuan, et al.
Publicado: (2022)

Bilateral Superior Cervical Sympathectomy Activates Signal Transducer and Activator of Transcription 3 Signal to Alleviate Myocardial Ischemia-Reperfusion Injury
por: Li, Lixia, et al.
Publicado: (2022)

Maslinic Acid Attenuates Ischemia/Reperfusion Injury-Induced Myocardial Inflammation and Apoptosis by Regulating HMGB1-TLR4 Axis
por: Li, Qi, et al.
Publicado: (2021)

Magnetocardiography for the detection of myocardial ischemia
por: Her, Ae-Young, et al.
Publicado: (2023)

Flavonoids in myocardial ischemia-reperfusion injury: Therapeutic effects and mechanisms
por: Jia, Jun-ying, et al.
Publicado: (2020)

LncRNA PVT1 Knockdown Ameliorates Myocardial Ischemia Reperfusion Damage via Suppressing Gasdermin D-Mediated Pyroptosis in Cardiomyocytes
por: Li, Cuizhi, et al.
Publicado: (2021)

miR-135b-3p Promotes Cardiomyocyte Ferroptosis by Targeting GPX4 and Aggravates Myocardial Ischemia/Reperfusion Injury
por: Sun, Weixin, et al.
Publicado: (2021)

Pre-clinical Evidence: Berberine as a Promising Cardioprotective Candidate for Myocardial Ischemia/Reperfusion Injury, a Systematic Review, and Meta-Analysis
por: Chen, Cong, et al.
Publicado: (2021)

Telomerase Deficiency Predisposes to Heart Failure and Ischemia-Reperfusion Injury
por: Ait-Aissa, Karima, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_adj53rsi8a5778crm9p0flm3dh